Ovarian function in patients with systemic lupus erythematosus: Pathogenesis, drug application and prospective...

Area of Science:

• Reproductive immunology
• Autoimmune disease research
• Pharmacology

Background:

• Systemic lupus erythematosus (SLE) is a chronic autoimmune condition affecting multiple organs, predominantly in women of reproductive age.
• Current treatments for SLE, including glucocorticoids and immunosuppressants, are associated with significant side effects.
• Ovarian dysfunction is a recognized complication in women treated for SLE, impacting fertility and reproductive health.

Purpose of the Study:

• To review current understanding of ovarian injury in systemic lupus erythematosus.
• To analyze the impact of common SLE treatments on ovarian function.
• To explore strategies for preserving or improving ovarian function in women with SLE who wish to conceive.

Main Methods:

• Literature review of recent studies on SLE, ovarian function, and reproductive health.
• Analysis of pharmacological effects of immunosuppressants and glucocorticoids on the female reproductive system.
• Synthesis of emerging therapeutic strategies for ovarian protection in SLE patients.

Main Results:

• Established link between SLE treatments and iatrogenic ovarian damage.
• Identified specific drugs and dosages associated with increased risk of ovarian dysfunction.
• Highlighted potential interventions and supportive therapies to mitigate treatment-induced ovarian injury.

Conclusions:

• Ovarian dysfunction is a critical concern for women with SLE undergoing treatment.
• A comprehensive approach is needed to balance SLE management with the preservation of reproductive potential.
• Further research into fertility-sparing strategies is essential for improving outcomes in SLE patients desiring children.